RAPT
RAPT Therapeutics Inc
Halal Rating :
Last Price
$1.21
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
-95.08%
Company Overview
Industries
Exchange
Next Earnings Date
RAPT Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and cancer. The company's lead programs include zelnecirnon (RPT193) for inflammatory diseases and tozorakimab (FLX475) for cancer treatment.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate RAPT Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.